Children's Mercy Hospital

Mercy Medical Center Physicians Named "TOP DOCS" by What's Up Media

Retrieved on: 
Tuesday, August 29, 2023
Mercy Hospital, Wrist, Gynecologic Oncology (journal), DRS, Multimedia, Children's Mercy Hospital, Publication, Patient, Physician, Gynaecology, Orthopedic surgery, Elbow, News, Nursing, Kent Island (Maryland), Media, Mercy

BALTIMORE, Aug. 29, 2023 /PRNewswire-PRWeb/ -- Mercy Medical Center physicians Dr. Susan Peeler(Gynecology), Dr. Teresa Diaz-Montes(Gynecologic Oncology), Dr. John-Paul Rue (Orthopedic Surgery/Sports Medicine at Mercy), Dr. Clayton Alexander (Orthopedic Surgery/The Shoulder, Elbow, Wrist and Hand Center at Mercy), and Dr. Kamala Littleton (Orthopedic Surgery/Orthopedics and Joint Replacement at Mercy) have been named "Top Docs" by What's Up Media.

Key Points: 
  • BALTIMORE, Aug. 29, 2023 /PRNewswire-PRWeb/ -- Mercy Medical Center physicians Dr. Susan Peeler (Gynecology), Dr. Teresa Diaz-Montes (Gynecologic Oncology), Dr. John-Paul Rue (Orthopedic Surgery/Sports Medicine at Mercy), Dr. Clayton Alexander (Orthopedic Surgery/The Shoulder, Elbow, Wrist and Hand Center at Mercy), and Dr. Kamala Littleton (Orthopedic Surgery/Orthopedics and Joint Replacement at Mercy) have been named "Top Docs" by What's Up Media.
  • Mercy's physicians were recognized as follows:
    The physicians honored represent the individuals who received the highest number of nominations from their peers.
  • "We are extremely gratified to see Mercy physicians in different specialties recognized by their peers for their skill and dedication.
  • Mercy Health Services includes Mercy Medical Center in Baltimore, Maryland, primary care and specialist locations in Canton, Columbia, Glen Burnie, Hunt Valley, Lutherville, Manchester, Overlea, and Reisterstown, as well as the Institute for Gynecologic Care at Annapolis, and Mercy Physicians at Kent Island.

Dr. William Adelman named medical director, CHOC Primary Care Network

Retrieved on: 
Thursday, July 27, 2023
Tufts University, Walter Reed Army Medical Center, University, Colonel, Army, Children's Mercy Hospital, Walter Reed National Military Medical Center, Senior counsel, Orange County, Mercy Hospital, United States Army, Medicine, Children's Hospital of Orange County, Science, Public sector, Student, Johns Hopkins University, Adolescence, Hospital, Health, CHOC, Adelman, Birth control, Nursing, Child

ORANGE, Calif., July 27, 2023 /PRNewswire/ -- Dr. William Adelman has joined Children's Hospital of Orange County (CHOC) as the new medical director of the CHOC Primary Care Network.

Key Points: 
  • ORANGE, Calif., July 27, 2023 /PRNewswire/ -- Dr. William Adelman has joined Children's Hospital of Orange County (CHOC) as the new medical director of the CHOC Primary Care Network.
  • "We are thrilled to welcome Dr. Adelman to CHOC.
  • His impressive experience in adolescent medicine, medical leadership and improvement science will help us continue to grow and enhance the pediatric and adolescent primary care services we provide across Southern California," said Dr Charles Golden, assistant chief medical officer, CHOC.
  • Dr. Adelman received his medical degree from Tufts University and did his post-graduate training at the Walter Reed Army Medical Center and National Capital Consortium in Bethesda, Maryland.

Cardio Diagnostics Holdings, Inc Welcomes Dr. Damon Broyles, MD, as Strategic Advisor for Precision Cardiovascular Medicine Strategy

Retrieved on: 
Wednesday, March 8, 2023
Technology, Medical Devices, Health Technology, Cardiology, Biotechnology, Health, Pharmaceutical, General Health, Artificial Intelligence, MD, Mercy (healthcare organization), Hospital, MTS, Growth, Children's Mercy Hospital, Cardiovascular disease, Intelligence, Acos, Medicine, Medical director, Entrepreneurship, Patient, Accountable care organization, VC, Knowledge, Medical device, Nursing, Mercy

Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), an artificial intelligence-powered precision cardiovascular medicine company, today announced Dr. Damon Broyles, MD, the VP of Clinical Innovation at Mercy Technology Services (MTS), the technical support arm of Mercy Healthcare, has joined Cardio Diagnostics as a strategic advisor.

Key Points: 
  • Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), an artificial intelligence-powered precision cardiovascular medicine company, today announced Dr. Damon Broyles, MD, the VP of Clinical Innovation at Mercy Technology Services (MTS), the technical support arm of Mercy Healthcare, has joined Cardio Diagnostics as a strategic advisor.
  • Strategic advisors at Cardio Diagnostics are pivotal in providing guidance and counsel to the management team.
  • "I am thrilled to join Cardio Diagnostics and contribute my expertise in healthcare innovation and precision medicine," says Dr. Damon Broyles, VP of Clinical Innovation at Mercy Technology Services.
  • With Dr. Broyles on board, we are excited to advance our mission of bringing artificial intelligence-powered precision cardiovascular medicine to patients worldwide."

Funding Renewed for Biotech Center, LSU One of Five Partners

Retrieved on: 
Tuesday, December 6, 2022
Precision medicine, Acquisition, Ion, Exosome, CBM2, Plastic, Nanofluidic circuitry, DNA, Mechanical, Stroke, University of Kansas Medical Center, Liquid biopsy, Mechanical engineering, Urine, National Cancer Institute, University, Wake Forest School of Medicine, LSU, University of North Carolina at Chapel Hill, Disease management, Children's Mercy Hospital, Cerebrospinal fluid, Research, Biomarker, Cancer, Infection, Blood, Seminal vesicles, Nanopore sequencing, Pharmaceutical industry, Renewable energy, Medicine

CBM2’s partners include LSU, the University of Kansas, the University of Kansas Medical Center, University of North Carolina-Chapel Hill, and Wake Forest School of Medicine.

Key Points: 
  • CBM2’s partners include LSU, the University of Kansas, the University of Kansas Medical Center, University of North Carolina-Chapel Hill, and Wake Forest School of Medicine.
  • The total amount of the center’s renewed five-year grant is nearly $6 million, while the LSU portion of the funds is just over $2 million.
  • LSU is represented in the center by Mechanical Engineering Professors Sunggook Park and Michael Murphy.
  • Also, the micro- and nanomanufacturing technologies that we are developing in LSU will contribute to the manufacturing sector of Louisiana industries.”

Hims & Hers appoints first-ever Chief Pharmacy & Innovation Officer

Retrieved on: 
Monday, December 5, 2022
Pharmaceutical, Health, Telemedicine, Virtual Medicine, Children's Mercy Hospital, Publication, Hims & Hers Health, Executive, Innovation, Howard Brody, Heel, Television, United Kingdom, Cleveland, University of Minnesota College of Pharmacy, Health minister, Chief innovation officer, Cleveland Clinic, M Health Fairview University of Minnesota Medical Center, Health, Hair loss, Patient, American Pharmacists Association, Radio, MS, NYSE, Homs, Prescription, Hospital pharmacy, Mental health, Pharmacist, Multimedia, University, Dermatology, University of Kansas Medical Center, Pharming, Northeast Ohio Medical University, University of Nebraska College of Law, Foot, Management, Pharmacy, Hers

Hims & Hers Health, Inc. (Hims & Hers, NYSE: HIMS), the trusted consumer-first platform focused on providing modern personalized health and wellness experiences to consumers, today made a key leadership appointment, naming pharmacy industry veteran Dr. Scott Knoer, Pharm.D., MS, FASHP, as the companys first-ever Chief Pharmacy & Innovation Officer.

Key Points: 
  • Hims & Hers Health, Inc. (Hims & Hers, NYSE: HIMS), the trusted consumer-first platform focused on providing modern personalized health and wellness experiences to consumers, today made a key leadership appointment, naming pharmacy industry veteran Dr. Scott Knoer, Pharm.D., MS, FASHP, as the companys first-ever Chief Pharmacy & Innovation Officer.
  • View the full release here: https://www.businesswire.com/news/home/20221205005225/en/
    Dr. Scott Knoer, Chief Pharmacy & Innovation Officer at Hims & Hers (Photo: Business Wire)
    In this role, Dr. Knoer will oversee pharmacy strategy and innovation efforts for Hims & Hers.
  • The addition of Dr. Knoer as Chief Pharmacy & Innovation Officer is the next step forward for our brand, our team and our solutions, said Andrew Dudum, Chief Executive Officer at Hims & Hers.
  • I am humbled by this opportunity to help define the future of modern healthcare and wellness, said Dr. Scott Knoer, Chief Pharmacy & Innovation Officer at Hims & Hers.

Wellish Vision Institute Announces Expansion in Southwest Las Vegas

Retrieved on: 
Thursday, November 24, 2022
LAS, University of Pittsburgh Medical Center, Glaucoma, University, University at Buffalo, Patient, Vision Institute, UCLA, UCL Ear Institute, Ophthalmology, National Institutes of Health Clinical Center, Tran, Moses Austin, Morale, Cornea, Children's Mercy Hospital, University of California, Davis, University of Kansas Medical Center, Cataract, Retina, Duane syndrome, University of Arizona, Business administration, Massachusetts Eye and Ear, Apache, Optometry, Buffalo, University of Texas Southwestern Medical Center, GVHD, University of Washington Department of Global Health, Fort Apache, Harvard University, Master of Business Administration, Hotel, Veterinary medicine, Medical device, Seattle metropolitan area

LAS VEGAS, Nov. 23, 2022 /PRNewswire-PRWeb/ -- Wellish Vision Institute is excited to announce they are expanding into Southwest Las Vegas to better serve patients living in this area of Las Vegas. The practice is located at 6710 South Apache Road. The new practice boasts 7,200 square feet and includes 14 exam rooms, all equipped with same state-of-the-art technology found at the other three Wellish Vision locations.

Key Points: 
  • Wellish Vision Institute is excited to announce they are expanding into Southwest Las Vegas to better serve patients living in this area of Las Vegas.
  • LAS VEGAS, Nov. 23, 2022 /PRNewswire-PRWeb/ -- Wellish Vision Institute is excited to announce they are expanding into Southwest Las Vegas to better serve patients living in this area of Las Vegas.
  • As part of this expansion, Wellish Vision Institute is also excited to announce well-respected ophthalmologist Dr. Andrew Tran and optometrist Dr. Tiffany Nguyen are joining the highly trained eye care team at Wellish Vision.
  • Wellish Vision Institute is one of the leading ophthalmology practices in Las Vegas.

Vial Welcomes Dr. Rajesh Pahwa, Chief of the Parkinson's and Movement Disorder Division at the University of Kansas Medical Center, to its Central Nervous System Scientific Advisory Board

Retrieved on: 
Thursday, November 17, 2022
Parkinson's Foundation, SAN, Excellent, ESourcing Capability Model, Neurology, CRO, Movement disorders, Technology, Gastroenterology, Parkinson, Partnership, Vial, Dermatology, University, Industry, Ophthalmology, Cardiology, Children's Mercy Hospital, Research, Multimedia, EDC, EPRO, Cras, Patient, University of Kansas Medical Center, Parkinson's disease, CNS, Central nervous system, Faculty, Digital technology, Fine chemical

SAN FRANCISCO, Nov. 16, 2022 /PRNewswire/ -- Vial welcomes Dr. Rajesh Pahwa as a new Central Nervous System (CNS) advisory board member to their Neurology CRO .

Key Points: 
  • SAN FRANCISCO, Nov. 16, 2022 /PRNewswire/ -- Vial welcomes Dr. Rajesh Pahwa as a new Central Nervous System (CNS) advisory board member to their Neurology CRO .
  • Dr. Pahwa joins fellow Vial scientific board members, Dr. Robert Hauser and Dr. Joseph Jankovic .
  • On the partnership, Dr. Pahwa shared, "I am delighted to join Vial's scientific advisory board and contribute to the evolution of their Neurology CRO.
  • Vial operates across multiple therapeutic areas ( Dermatology CRO , Ophthalmology CRO , Oncology CRO , Gastroenterology CRO , Neurology CRO , and Cardiology CRO ).

Kinimmune wins highly competitive NCI funding to advance solid tumor immunotherapy for patients refractory to checkpoint inhibitors

Retrieved on: 
Wednesday, November 9, 2022
Oncology, FDA, Health, Clinical Trials, Pharmaceutical, Biotechnology, COO, National, Vaccine, Glatiramer acetate, Tumor microenvironment, National Cancer Institute, University of Kansas Medical Center, STTR, Children's Mercy Hospital, CpG, TLR9, King Abdulaziz University, Neoplasm, Ligation, Safety, Infection, Cory, Cancer, Lymph, CSO, University, Patient, Immune system, NCI, FDA, Pharmaceutical industry

The STTR program at NCI is designed to fuel small businesses on the cutting edge of innovation with nondilutive funding to de-risk and advance promising cancer interventions.

Key Points: 
  • The STTR program at NCI is designed to fuel small businesses on the cutting edge of innovation with nondilutive funding to de-risk and advance promising cancer interventions.
  • STTR grants from the NCI are highly selective and were awarded to just 15% of applicants in 2021.
  • Winning this award provides invaluable scientific validation in addition to the research funding, shared Cory Berkland, President and Co-founder of Kinimmune.
  • This award from the NCI will help Kinimmune continue the preclinical development of KIN-102, shared Nabil Alhakamy, COO and Co-Founder of Kinimmune.

The Children's Mercy Kansas City Research Institute Pioneers Most-Advanced Genomic Sequencing System in the World

Retrieved on: 
Monday, September 19, 2022
Magnet, YouTube, Faculty, Laboratory, FRS, Twitter, Database, Hospital, Hassenfeld Children's Hospital, NYU Langone Health, Hope, News, LinkedIn, Senior, Degenerative disease, Catholic University of Leuven (1834–1968), Program, Genetics, Preprint, Children's Mercy Hospital, Technology, Instagram, Genetic testing, Mercy, Patient, Family, Doctor of Philosophy, Science, Diagnosis, Research, DNA, Genetic code, Genome, Education, Disease, Antibiotics, Vaccine, Medicine, MD, Child, Kansas City metropolitan area, Facebook, Genomics

KANSAS CITY, Mo., Sept. 19, 2022 /PRNewswire/ -- The Children's Mercy Kansas City Research Institute announced it has pioneered advances in the human genome using 5-base genomic sequencing that transforms diagnosing and understanding of unsolved pediatric disease.

Key Points: 
  • KANSAS CITY, Mo., Sept. 19, 2022 /PRNewswire/ -- The Children's Mercy Kansas City Research Institute announced it has pioneered advances in the human genome using 5-base genomic sequencing that transforms diagnosing and understanding of unsolved pediatric disease.
  • Thanks to $18.5 million in philanthropic funding, Dr. Pastinen started the Genomic Answers for Kids (GA4K) program at Children's Mercy, a first-of-its-kind pediatric data repository.
  • "The hope that 5-base sequencing offers our families is truly transformative to children not only here in the Kansas City region but across the globe.
  • Visit Children's Mercy and the Children's Mercy Research Institute to learn more, and follow us on Facebook , LinkedIn , Twitter , Instagram and YouTube for the latest news and videos.

OXEIA ANNOUNCES POSITIVE INTERIM RESULTS OF PHASE 2 TRIAL FOR OXE103 FOR THE TREATMENT OF CONCUSSIONS

Retrieved on: 
Wednesday, August 3, 2022
Human, Neuro, Appetite, Brain, Children's Mercy Hospital, Patient, Memory, Concussion, Reactive oxygen species, Diffuse axonal injury, Neurology, GLOBE, Medicine, University of Kansas Medical Center, University, University of San Francisco School of Nursing and Health Professions, Traffic barrier, Ghrelin, Cognition, Pharmaceutical industry, Medical device, Nursing

The trial is focusing on treatment for subjects within 28 days of injury who are highly symptomatic at screening.

Key Points: 
  • The trial is focusing on treatment for subjects within 28 days of injury who are highly symptomatic at screening.
  • This group represents the majority of concussion patients who do not seek treatment immediately following their injury.
  • According to Oxeia CEO, Dr. Michael Wyand, I am encouraged by the interim results we are seeing from the trial.
  • The interim data provide hope for an effective treatment for the millions of people who suffer ongoing post-concussion symptoms due to a lack of effective treatment options.